Detalhe da pesquisa
1.
Vaccine Effectiveness Against SARS-CoV-2 Infection and Severe Outcomes in the Maintenance Dialysis Population in Ontario, Canada.
J Am Soc Nephrol
; 33(4): 839-849, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35264455
2.
COVID-19 in patients undergoing long-term dialysis in Ontario.
CMAJ
; 193(8): E278-E284, 2021 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33542093
3.
Impact of study design on vaccine effectiveness estimates of 2 mRNA COVID-19 vaccine doses in patients with stage 5 chronic kidney disease.
Kidney Int
; 103(4): 791-797, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36731610
4.
COVID-19 chez les patients ontariens sous dialyse à long terme.
CMAJ
; 193(18): E655-E662, 2021 05 03.
Artigo
em Francês
| MEDLINE | ID: mdl-33941528
5.
Comparison of Acute Health Care Utilization Between Patients Receiving In-Center Hemodialysis and the General Population: A Population-Based Matched Cohort Study From Ontario, Canada.
Can J Kidney Health Dis
; 11: 20543581241231426, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38449711
6.
Infection Control Practices in In-Center Hemodialysis Units During Wave 1 of the COVID-19 Pandemic in Ontario, Canada: Research Letter.
Can J Kidney Health Dis
; 10: 20543581221146033, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36654932
7.
Clinical Outcomes and Vaccine Effectiveness for SARS-CoV-2 Infection in People Attending Advanced CKD Clinics: A Retrospective Provincial Cohort Study.
Clin J Am Soc Nephrol
; 18(4): 465-474, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36795940
8.
Early Experience with Modified Dose Nirmatrelvir/Ritonavir in Dialysis Patients with Coronavirus Disease 2019.
Clin J Am Soc Nephrol
; 18(4): 485-490, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36723285
9.
Effectiveness of Three Doses of mRNA COVID-19 Vaccines in the Hemodialysis Population during the Omicron Period.
Clin J Am Soc Nephrol
; 18(4): 491-498, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36723290
10.
Acute kidney injury requiring renal replacement therapy in people with COVID-19 disease in Ontario, Canada: a prospective analysis of risk factors and outcomes.
Clin Kidney J
; 15(3): 507-516, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35198157
11.
Province-Wide Prevalence Testing for SARS-CoV-2 of In-Center Hemodialysis Patients and Staff in Ontario, Canada: A Cross-Sectional Study.
Can J Kidney Health Dis
; 8: 20543581211036213, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34394945
12.
Growing home dialysis: The Ontario Renal Network Home Dialysis Initiative 2012-2019.
Perit Dial Int
; 41(5): 441-452, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33969759
13.
Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD.
Clin J Am Soc Nephrol
; 17(8): 1247-1250, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35680135
14.
COVID-19 among Adults Receiving Home versus In-Center Dialysis.
Clin J Am Soc Nephrol
; 16(9): 1410-1412, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34088719
15.
HDAC inhibitor M344 suppresses MCF-7 breast cancer cell proliferation.
Biomed Pharmacother
; 66(3): 232-6, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22436652